WHO South-East Asia Journal of Public Health
  • 150
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Medicine Safety Monitoring in Pediatric Population in India
Ismeet Kaur,Vivekanandan Kalaiselvan,Gyanendra N. Singh
The Indian Journal of Pediatrics.2016;83(5)479
[DOI]
2Materiovigilance: Concept, Structure and Emerging Perspective for Patientís Safety in India
Farazul Hoda,Rishabh Verma,Mawrah Arshad,Ali Nasir Siddiqui,Mohammad Ahmed Khan,Mohammad Akhtar,Abul Kalam Najmi
Drug Research.2020;70(09)429
[DOI]
3Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience
Vivekanandan Kalaiselvan,Shatrunajay Shukla,Shubhang Arora,Tarani Prakash Shrivastava,Rajeev Singh Raghuvanshi
Frontiers in Public Health.2022;10(09)429
[DOI]
4Implementation of adverse event reporting for medical devices, India
Shatrunajay Shukla,Madhur Gupta,Sabitri Pandit,Milu Thomson,Abhimanyu Shivhare,Vivekanandan Kalaiselvan,Gyanendra Nath Singh
Bulletin of the World Health Organization.2020;98(3)206
[DOI]
5Implementation of adverse event reporting for medical devices, India
Vivekanandan Kalaiselven,Shatrunajay Shukla,Nikita Mishra,Pawan Kumar
Bulletin of the World Health Organization.2021;98(3)206
[DOI]
6Adverse drug reactions due to ophthalmic drugs: Reporting system in India
Vivekanandan Kalaiselvan,Prabhakar Mishra,GyanendraNath Singh
Indian Journal of Ophthalmology.2016;64(3)255
[DOI]
7Adverse drug reactions due to ophthalmic drugs: Reporting system in India
A. N. Nagappa,Jovita Kanoujia
Indian Journal of Ophthalmology.2022;64(3)181
[DOI]
8Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
Vivekanandan Kalaiselvan,Ismeet Kaur,Vipin Kumar,Gyanendra N. Singh
Indian Heart Journal.2015;67(6)613
[DOI]
9Pharmacovigilance in drugs used in the treatment of drug dependence
Anusha Thota,Prasad Thota,Vivekanandan Kalaiselvan,Siddharth Sarkar,GyanendraNath Singh
Indian Journal of Psychiatry.2017;59(3)393
[DOI]
10A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations
Deeksha Joshi,Ishita Sharma,Saurabh Gupta,Thakur Gurjeet Singh,Sonia Dhiman,Abhimanyu Prashar,Monica Gulati,Bimlesh Kumar,Sukriti Vishwas,Dinesh Kumar Chellappan,Gaurav Gupta,Niraj Kumar Jha,Piyush Kumar Gupta,Poonam Negi,Kamal Dua,Sachin Kumar Singh
Environmental Science and Pollution Research.2021;28(42)59608
[DOI]
11System of adverse drug reactions reporting: What, where, how, and whom to report?
Vivekanandan Kalaiselvan,Pranay Kumar,Prabhakar Mishra,Gyanendra Singh
Indian Journal of Critical Care Medicine.2015;19(9)564
[DOI]
12Self-Reporting of Adverse Drug Reactions in Iraqi Hospitals: Patientís Perspectives
Kadhim Ali Kadhim
Pharmacology & Pharmacy.2015;06(12)566
[DOI]
13Self-Reporting of Adverse Drug Reactions in Iraqi Hospitals: Patientís Perspectives
Ram Samujh,Nitin J. Peters
Pharmacology & Pharmacy.2022;06(12)497
[DOI]
14Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
Pramod Kumar,Ismeet Kaur,Vivekanandan Kalaiselvan,Abhishank Singh
Indian Journal of Anaesthesia.2017;61(7)534
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal